Home

System medicine is the future of health care with herbal medicine playing an essential role

System medicine is the future of health care with herbal medicine playing an essential role

Perspective: The next generation Health care will aim at prevention or treatment of chronic diseases and health promotion. SU BioMedicine has cutting edge knowledge  and the research network for generating systems medicine for these developments. SU BioMedicine is a company with numerous collaborations and with all technology based research being performed in Europe. Its Chinese network is at a very high unique level, including  the government and the most innovative industries and research institutes in Chinese medicine in China.

Products portfolio: Chinese herbal medicine in treatment/ prevention of diseases in the area of pain, woman’s health, cold etc.

About us

Our History

Our History

SU BioMedicine (SUB) was established as a spin-off company from the Netherlands Applied Science ORGANISATION (TNO). SU BioMedicine is based on its unique expertise in Chinese Herbal Medicine with respect to quality, safety, efficiency, registration procedures in the European Union and commercialization in the EU. The business model of SU BioMedicine is to provide scientific evidence using modern scientific technologies/pharmacology and to perform registration and commercialization of the Chinese herbal products in the EU. SU BioMedicine collaborates with research institutions globally, for scientific evidence of the efficacy of Chinese herbal medicine and novel quality control. SU BioMedicine also works together with Chinese Medicine producers to arrange for EU GMP standards for production. SU BioMedicine is involved in establishment of Chinese herbal medicine monographs according to the European pharmacopeia quality standard. It functions as a bridge between Chinese and European pharmaceutical companies.

Mission
SU BioMedicine collaborates with scientific communities for scientific evidence and quality control of Chinese herbal medicine. SU BioMedicine also works together Chinese pharmaceutical companies and introduces Herbal Medicines on the European market as Herbal Medicine with scientific proven safety and efficacy to address the worldwide unmet medical need for treatment of various (chronic) diseases.

Technology

Products

DXXK

DXXK

SUB creates value by owning a portfolio of approved Chinese herbal medicine and by commercialization in EU.

Achievements: SU BioMedicine has realized, as the first company in the world, the registration of a Chinese medicinal product according to tHMP (traditional Herbal medicinal product) rules (directive 2004/24/EC) in Europe that is produced in China. A press conference was given on April 18, 2012 and organized by the Chinese government minister of Health Chen Zhu, the vice president of the National People’s congress San Guo Wei and the Chinese Academy of Sciences in the prestigious People’s Hall in Beijing. Present were 400 people from the press including CCTV.

Products portfolio: Chinese herbal medicine in treatment/ prevention of diseases in the area of pain, woman’s health, cold etc.

Contact Us

Please contact us:

Please contact us:

SU BioMedicine BV
Postbus 546
2300 AM Leiden
The Netherlands

E-mail: info@subiomedicine.com

News

Updates

Updates

In 2012 SU BioMedicine’s project with Diao was chosen as one of the 10 most scientific innovative achievements by the Chinese Academy of Sciences, Chinese Academy of Engineering, the Ministry of Science and Technology and the Nature Science foundation.

Traditional Medicine International Cooperation Forum (2017 TMIF), Macao, the P.R. China, 26-29 Sept 2017.

XIX Pharmaceutical Congress of São Paulo, Brazil, 6-8 October 2017.